The Potential Benefit of Telmisartan to Protect Overweight Patients with COPD from the Acquisition of COVID-19.

Kow, Chia Siang; Hasan, Syed Shahzad

Kow, Chia Siang; Hasan, Syed Shahzad.

Kow CS; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.
Hasan SS; Department of Pharmacy, University of Huddersfield, Huddersfield, UK.

Obesity (Silver Spring) ; 28(11): 2035, 2020 11.

Article in English | MEDLINE | ID: covidwho-659657

Subject(s)

Angiotensin II Type 1 Receptor Blockers/therapeutic use; Betacoronavirus/pathogenicity; Coronavirus Infections/drug therapy; Overweight/drug therapy; Pneumonia, Viral/drug therapy; Pulmonary Disease, Chronic Obstructive/complications; Telmisartan/therapeutic use; Angiotensin II Type 1 Receptor Blockers/pharmacology; Animals; COVID-19; Female; Humans; Male; Mice; Overweight/complications; Pandemics; Rats; SARS-CoV-2; Telmisartan/pharmacology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pulmonary Disease, Chronic Obstructive / Angiotensin II Type 1 Receptor Blockers / Overweight / Betacoronavirus / Telmisartan Topics: Long Covid Limits: Animals / Female / Humans / Male Language: English Journal: Obesity (Silver Spring) Journal subject: Nutritional Sciences / Physiology / Metabolism Year: 2020 Document Type: Article Affiliation country: Oby.22976

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google